| Date |
Conference |
Title |
| 2013 February |
International Society for CNS Clinical Trial Methodology |
Abuse liability workshop |
| 2012 June |
College on Problem of Drug Dependence Conference |
Assessment of Abuse Deterrent and Tamper Resistant Technologies: From the Bench-top to the Users (workshop) |
| 2012 February |
International Society for CNS Clinical Trial Methodology |
Discussion of Draft Abuse Liability Assessment Decision Tree – Review of Case Studies (workshop) |
| 2011 November |
Science of Abuse Liability Assessments Meeting |
Human Abuse Liability Studies: Discussions of Various Applications and Limitations During Testing (seminar presentation) |
| 2011 June |
College on Problem of Drug Dependence |
FDA draft guidance: Testing of the abuse potential of compounds – November 2010 Dialogue between Industry and the FDA controlled substance staff (workshop) |
| 2011 March |
Society of Toxicology Meeting |
Design and Interpretation of Clinical Trials Evaluating Abuse Potential of Drugs: Where are the Gaps? (seminar presentation) |
| 2010 November |
Workshop presentation at the FDA / Industry (Cross Company Abuse Liability Consortium) Dialogue II Session |
Clinical Abuse Liability Assessments (workshop) |
| 2010 August |
13th Congress of the International Association for the Study of Pain |
Can Increasing Mechanical Stability of Controlled Released Tablets Decrease Drug Preference and the Street Value of the Drug? (poster) |
| 2010 June |
College on Problem of Drug Dependence |
Current Issues in Clinical Trial Design for Assessment of Abuse Potential of Novel Pharmaceuticals (seminar presentation) |
| 2010 June |
College on Problem of Drug Dependence |
Pattern of OxyContin Use in Opioid Abusers Experienced in Tampering with the Formulation – A Retrospective Assessment of Drug Administration Methods from the Frist Use to the Current Proffered Method (poster) |
